2,4,6-Triphenylpyrimidine

Catalog No.: 
ACMUXS591
CAS No.: 
1666-86-0
Molecular Formula: 
C22H16N2
Molecular Weight: 
308.38
2,4,6-Triphenylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$73.00InquiryInquiry
1g97%$185.00InquiryInquiry
5g97%$556.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4,6-Triphenylpyrimidine
IUPAC Name2,4,6-triphenylpyrimidine
Molecular FormulaC22H16N2
Molecular Weight308.38
SMILESC1(C2=CC=CC=C2)=NC(C3=CC=CC=C3)=CC(C4=CC=CC=C4)=N1
InChI KeySZKWMQWGJPCXOF-UHFFFAOYSA-N
Synonym2,4,6-TRIPHENYLPYRIMIDINE;Pyrimidine, 2,4,6-triphenyl-
CAS No.1666-86-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACMUXS591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMPTB271 route compound structure diagram
    ACMPTB27129509-91-9In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACMUXS591 route product structure diagram
    ACMUXS5911666-86-0
Inquiry

2. ACMUXS591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLNXG621 route compound structure diagram
    ACLNXG6212915-16-4In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACMUXS591 route product structure diagram
    ACMUXS5911666-86-0
Inquiry

3. ACMUXS591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNOT025 route compound structure diagram
    ACBNOT02556181-49-8In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACMUXS591 route product structure diagram
    ACMUXS5911666-86-0
Inquiry

Comments (0)